Quantitative determination of CGS 26214, a cholesterol lowering agent, in human plasma using negative electrospray ionization liquid chromatography-tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-08-05
著者
-
Tse Francis
Department Of Drug Metabolism And Pharmacokinetics Novartis Institutes For Biomedical Research
-
Majumdar Tapan
Department Of Drug Metabolism & Pharmacokinetics Novartis Institute For Biomedical Research
-
WU Shari
Department of Drug Metabolism & Pharmacokinetics, Novartis Institute for Biomedical Research
-
Wu Shari
Department Of Drug Metabolism & Pharmacokinetics Novartis Institute For Biomedical Research
-
Tse Francis
Department Of Drug Metabolism & Pharmacokinetics Novartis Institute For Biomedical Research
関連論文
- Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS : Prevention and recovery of lost analyte due to container surface adsorption
- Simultaneous determination of ribavirin and ribavirin base in monkey plasma by high performance liquid chromatography with tandem mass spectrometry
- A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon-α_ in human serum using monolithic C_ solid phase extraction for enrichment
- Quantitative determination of CGS 26214, a cholesterol lowering agent, in human plasma using negative electrospray ionization liquid chromatography-tandem mass spectrometry